BioInfra Co., Ltd.

BioInfra Co., Ltd. is a contract research organization specializing in phase 1 clinical trials. It provides clinical services for new drug development approval (Phase I–III) and late-stage trials, immunoassay services including pharmacokinetic, toxicokinetic, and biomarker analysis of polymer biopharmaceuticals, and testing and inspection services such as finished drug product quality inspection, comparative dissolution testing, and long-term stability testing. The company also specializes in bioequivalence testing of generic drugs, phase 1 clinical trials for new and improved drugs, and sample analysis services for new drug substances. Founded in 2007, it is based in Yongin-si, South Korea.